How innovative drug delivery devices can help realise clinical utility of new effective therapies

The limited ability to selectively deliver drug molecules at well-defined dosing regimens remains a significant challenge. Therefore, the delivery of effective therapies relies on the improvement of current carriers. Due to the clear lack of novel drugs and patent expiry of blockbuster molecules, novel drug delivery systems need to be used and teach new tricks to old drugs. Thus, the fundamental question, which will be answered in this editorial, is how we move from the current treatment approaches to an innovative one by using new drug delivery devices.